Scilex Holding (SCLX) Free Cash Flow (QoQ) (2020 - 2026)

Scilex Holding (SCLX) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 105.15%
Dec 31, 2025 -313.40%
Sep 30, 2025 15.42%
Jun 30, 2025 18.08%
Mar 31, 2025 137.06%
Dec 31, 2024 -50.44%
Sep 30, 2024 121.25%
Jun 30, 2024 -75.39%
Mar 31, 2024 274.20%
Dec 31, 2023 -191.70%
Sep 30, 2023 143.64%
Jun 30, 2023 -73.98%
Mar 31, 2023 -968.14%
Dec 31, 2022 -128.70%
Sep 30, 2022 120.48%
Jun 30, 2022 -14.95%
Mar 31, 2022 61.63%
Dec 31, 2021 -19,600.37%
Sep 30, 2021 74.26%
Jun 30, 2021 -11.59%